Clinical trial Ro-CHOP
RoCHOP Phase 3 multi-center randomized study to compare efficacy and safety of Romidepsin-CHOP (Ro-CHOP) versus CHOP in subjects with previously untreated peripheral T-Cell Lymphoma
Cancers | |
---|---|
Organ | Lymphoma |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
EudraCT Identifier | 2012-001580-68 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01796002 |
Inclusion criteria | histologically proven peripheral T-cell lymphoma (PTCL) |
Last update |